Rosemont acquires Lucis Pharma to boost portfolio
Company will gain access to a considerable pipeline of liquid products covering various disease areas
Read More
Search Results for: Various
Debiopharm commences pivotal glioblastoma therapy study
The therapy is a brain-penetrant used in various combinations in patients with progressive glioblastoma
Read More
The patent waiver debate
In recent months an intense debate has arisen about a potential waiving of patent rights on COVID vaccines. This article looks at the background to this debate, the relevance of patent rights to the COVID vaccines and the various issues raised by the different protagonists.
Read More
NICE to reassess Kyowa Kirin’s Poteligeo
An appeal lodged by the company and various charities has been upheld by an independent appeal panel
Read More
AZ, Accent to develop therapies targeting RNA-modifying proteins
These proteins control various aspects of RNA biology and represent a new target for cancer treatment
Read More- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
